Back to briefingOn watchUnited KingdomPolicy & regulationSep 1, 2026, 6:58 PMUK regulator suspends Amgen rare-disease drug Tavneos for new patientsUK regulator suspends Amgen rare-disease drug Tavneos for new patientsRead original sourceToday's stories